| SART3 |
SART3, KIAA0156, TIP110: Squamous cell carcinoma antigen recognized by T-cells 3 |
RBM14 |
RBM14, SIP: RNA-binding protein 14 |
0.255 |
Evidence |
|
| SART3 |
SART3, KIAA0156, TIP110: Squamous cell carcinoma antigen recognized by T-cells 3 |
CPSF6 |
CPSF6, CFIM68: Cleavage and polyadenylation specificity factor subunit 6 |
0.255 |
Evidence |
|
| OPCML |
OPCML, OBCAM: Opioid-binding protein/cell adhesion molecule precursor |
CDH10 |
CDH10: Cadherin-10 precursor |
0.255 |
Evidence |
|
| OPCML |
OPCML, OBCAM: Opioid-binding protein/cell adhesion molecule precursor |
SCN3B |
SCN3B, KIAA1158: Sodium channel subunit beta-3 precursor |
0.255 |
Evidence |
|
| ZNF638 |
ZNF638, NP220, ZFML: Zinc finger protein 638 |
HNRPDL |
IPI00011274 |
0.255 |
Evidence |
|
| CHD4 |
CHD4: Chromodomain-helicase-DNA-binding protein 4 |
LSM4 |
LSM4: U6 snRNA-associated Sm-like protein LSm4 |
0.255 |
Evidence |
|
| CHD4 |
CHD4: Chromodomain-helicase-DNA-binding protein 4 |
LSM7 |
LSM7: U6 snRNA-associated Sm-like protein LSm7 |
0.255 |
Evidence |
|
| STAT4 |
STAT4: Signal transducer and activator of transcription 4 |
LDLRAP1 |
LDLRAP1, ARH: Low density lipoprotein receptor adapter protein 1 |
0.255 |
Evidence |
|
| IRF3 |
IRF3: Interferon regulatory factor 3 |
CCNL2 |
CCNL2, SB138: Cyclin-L2 |
0.255 |
Evidence |
|
| ZNF266 |
ZNF266, KIAA2007: Zinc finger protein 266 |
RNF125 |
RNF125: E3 ubiquitin-protein ligase RNF125 |
0.255 |
Evidence |
|
| HABP2 |
HABP2, HGFAL, PHBP: Hyaluronan-binding protein 2 precursor |
HP |
HP: Haptoglobin precursor [Contains: Haptoglobin alpha chain; Haptoglobin beta c |
0.255 |
Evidence |
|
| HABP2 |
HABP2, HGFAL, PHBP: Hyaluronan-binding protein 2 precursor |
C6 |
C6: Complement component C6 precursor |
0.255 |
Evidence |
|
| HABP2 |
HABP2, HGFAL, PHBP: Hyaluronan-binding protein 2 precursor |
C3 |
|
0.255 |
Evidence |
|
| HABP2 |
HABP2, HGFAL, PHBP: Hyaluronan-binding protein 2 precursor |
ALB |
ALB: Uncharacterized protein ALB |
0.255 |
Evidence |
|
| FGL2 |
FGL2: Fibroleukin precursor |
LOC645419 |
MEGF9, EGFL5, UNQ671/PRO1305, KIAA0818: Multiple epidermal growth factor-like do |
0.255 |
Evidence |
|
| FGL2 |
FGL2: Fibroleukin precursor |
CD93 |
CD93, C1QR1, MXRA4: Complement component C1q receptor precursor |
0.255 |
Evidence |
|
| TRIM14 |
TRIM14, KIAA0129: Tripartite motif-containing protein 14 |
ZNF394 |
ZNF394, ZKSCAN14: Zinc finger protein 394 |
0.255 |
Evidence |
|
| IL10RA |
IL10RA, IL10R: Interleukin-10 receptor alpha chain precursor |
IL27RA |
IPI00006774 |
0.255 |
Evidence |
|
| MFAP5 |
MFAP5, MAGP2: Microfibrillar-associated protein 5 precursor |
LAMA2 |
LAMA2: Uncharacterized protein LAMA2 |
0.255 |
Evidence |
|
| KLF1 |
KLF1, EKLF: Krueppel-like factor 1 |
TRIM10 |
TRIM10, RFB30, RNF9: Tripartite motif-containing protein 10 |
0.255 |
Evidence |
|
| SP140 |
SP140, LYSP100: Nuclear body protein SP140 |
ZHX2 |
ZHX2, AFR1, KIAA0854, RAF: Zinc fingers and homeoboxes protein 2 |
0.255 |
Evidence |
|
| PABPC4 |
PABPC4, APP1, PABP4: Polyadenylate-binding protein 4 |
CPSF6 |
CPSF6, CFIM68: Cleavage and polyadenylation specificity factor subunit 6 |
0.255 |
Evidence |
|
| SLAMF1 |
SLAMF1, SLAM: Signaling lymphocytic activation molecule precursor |
ICOS |
ICOS, AILIM: Inducible T-cell co-stimulator precursor |
0.255 |
Evidence |
|
| SFRS5 |
SFRS5, HRS, SRP40: Splicing factor, arginine/serine-rich 5 |
HNRPDL |
IPI00011274 |
0.255 |
Evidence |
|
| SFRS5 |
SFRS5, HRS, SRP40: Splicing factor, arginine/serine-rich 5 |
PARP12 |
PARP12, ZC3HDC1: Poly [ADP-ribose] polymerase 12 |
0.255 |
Evidence |
|